
Please try another search
Lasa Supergenerics Limited engages in the research, manufacture, and marketing of animal and human healthcare products in India. It offers API bulk drug products comprising fenbendazole, toldimphos sodium, cyromazine, albendazole, ricobendazole, triciabendazole, oxfendazole, closantel base, closantel sodium dihydrate BP, nitroxynil, rafoxanide, oxyclozanide, ornidazole, halquinol, and 2,6-diiodo-4-nitrophenol; and other API products. The company also provides animal feed ingredients, including calcium iodate; and reagents for therapeutic use, such as potassium iodide. In addition, it exports its products. Lasa Supergenerics Limited was incorporated in 2016 and is based in Ratnagiri, India.
Name | Age | Since | Title |
---|---|---|---|
Omkar Pravin Herlekar | 44 | 2016 | Chairman & MD |
Yogesh Hari Ughada | 22 | 2025 | Additional Independent Director |
Pravin Gadalya Lachake | 28 | 2025 | Additional Independent Director |
Ketan Bhau Songal | 24 | 2025 | Additional Independent Director |
Prathamesh Chalke | - | 2025 | Whole-Time Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review